(Q41164545)

27 September 2017

1 reference

title

Multiple myeloma, high-dose treatment and autologous stem cell transplantation--current status (English)

1 reference

27 September 2017

B Björkstrand

1

1 reference

27 September 2017

publication date

1 March 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

13

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

23-30

1 reference

Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden

27 September 2017

cites work

1 reference

12 December 2020

Autologous bone marrow transplantation for myeloma patients using PNA- and CD19-purged marrow rescue

1 reference

12 December 2020

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma

1 reference

12 December 2020

High-risk multiple myeloma treated with high-dose melphalan

1 reference

12 December 2020

Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies.

1 reference

12 December 2020

Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma.

1 reference

12 December 2020

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.

1 reference

12 December 2020

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

1 reference

12 December 2020

Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors.

1 reference

12 December 2020

Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy

1 reference

12 December 2020

The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma

1 reference

12 December 2020

Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors

1 reference

12 December 2020

High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myeloma

1 reference

12 December 2020

Limited value of myeloablative therapy for late multiple myeloma.

1 reference

12 December 2020

Prognostic factors with high-dose melphalan for refractory multiple myeloma.

1 reference

12 December 2020

High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants.

1 reference

12 December 2020

Prognostic Factors in Autologous Stem Cell Transplantation for Multiple Myeloma: An EBMT Registry Study

1 reference

12 December 2020

Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high-dose chemotherapy

1 reference

12 December 2020

Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts

1 reference

12 December 2020

Generation of anti-tumour activity by OKT3-stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis

1 reference

12 December 2020

Suicide gene therapy for plasma cell tumors.

1 reference

12 December 2020

Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

1 reference

12 December 2020

Intensive treatment of multiple myeloma and criteria for complete remission

1 reference

12 December 2020

Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies

1 reference

12 December 2020

Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.

1 reference

12 December 2020

Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients

1 reference

12 December 2020

High dose melphalan and autologous bone marrow transplantation in high risk myeloma

1 reference

12 December 2020

High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients.

1 reference

12 December 2020

Intensive combined therapy for previously untreated aggressive myeloma

1 reference

12 December 2020

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma

1 reference

12 December 2020

Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma

1 reference

12 December 2020

Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study Group

1 reference

12 December 2020

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

12 December 2020

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma

1 reference

12 December 2020

Evidence that long-term bone marrow culture of patients with multiple myeloma favors normal hemopoietic proliferation

1 reference

12 December 2020

Human long-term bone marrow cultures (HLTBMCs) in myelomatous disorders

1 reference

12 December 2020

A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma.

1 reference

12 December 2020

Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy

1 reference

12 December 2020

Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma

1 reference

12 December 2020

Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells

1 reference

12 December 2020

Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents

1 reference

12 December 2020

Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation

1 reference

12 December 2020

Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.

1 reference

12 December 2020

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

1 reference

12 December 2020

High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma

1 reference

12 December 2020

Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells

1 reference

12 December 2020

Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma

1 reference

12 December 2020

Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myeloma

1 reference

12 December 2020

Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide

1 reference

12 December 2020

Comparative survival, quality of life and cost-effectiveness of intensive therapy with autologous blood cell transplantation or conventional chemotherapy in multiple myeloma

1 reference

12 December 2020

High-dose melphalan for multiple myeloma: long-term follow-up data

1 reference

12 December 2020

Bone marrow transplantation in multiple myeloma

1 reference

12 December 2020

The in vitro effect of leucocyte alpha-interferon on human myeloma cells in a semisolid agar culture system.

1 reference

12 December 2020

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

1 reference

12 December 2020

Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients

1 reference

12 December 2020

Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden

1 reference

12 December 2020

High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting

1 reference

12 December 2020

Double-intensive therapy in high-risk multiple myeloma.

1 reference

12 December 2020

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1 reference

12 December 2020

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

1 reference

12 December 2020

Idiotype-specific T cells in multiple myeloma: targets for an immunotherapeutic intervention?

1 reference

12 December 2020

Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma.

1 reference

12 December 2020

Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.

1 reference

12 December 2020

Hematopoietic stem cell autografts in support of myeloablative therapy for multiple myeloma

1 reference

12 December 2020

Stem cell self-renewal considerations in bone marrow transplantation

1 reference

12 December 2020

Graft-versus-myeloma effect: proof of principle

1 reference

12 December 2020

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

1 reference

12 December 2020

Normal myeloid progenitors (CFU-GM) in multiple myeloma: a preliminary study in view of autologous BMT.

1 reference

12 December 2020

Detection of Immunoglobulin Gene Rearrangement in B Cell Neoplasias by Polymerase Chain Reaction Gene Amplification

1 reference

12 December 2020

Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma

1 reference

12 December 2020

Multiple myeloma treated with high dose intravenous melphalan

1 reference

12 December 2020

Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02988838

1 reference

Dimensions Publication ID

27 September 2017

1029555066

0 references

1 reference